Find the Perfect Plan for Your Investment Journey
C
Latest price
52 Week Range
HK$2.48 - HK$19.78
Next Earnings Date
May 21 2025 (Estimate)
Next Earnings Date
May 21 2025 (Est.)
Latest price
Market Cap | HK$8.63B |
EV | HK$7.24B |
Shares Outstanding | 559.97M |
Beta | 0.39 |
Analyst Rating | UNDERPERFORM |
Analyst Target Price | HK$8.43 |
P/E 2025E | - |
P/Revenue 2025E | 88.70x |
Revenue | 15.20% |
EPS | -0.50% |
Operating Cash Flow | 7.20% |
Free Cash Flow | 4.10% |
Revenue | 185.10% |
EPS | 31.20% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 64.00% |
Net Profit Margin 2025E | -515.07% |
ROE 2025E | -81.69% |
ROCE 2024 | -55.84% |
DPS 2025E | HK$0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
C
CARsgen Therapeutics Holdings Limited
2171
Sector
Healthcare
Industry
Biotechnology
CEO
Li, Zonghai
Employees
465
Website
www.carsgen.comIPO Date
2021-06-18
Headquarters
No. 466 Yindu Road, 1st Floor, Building 2, Xuhui District, Shanghai China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved